Until now, data from insulin pens was self-reported and subject to error, or often simply not captured,” Russ Johannesson, CEO of Glooko, said in a statement. “Our partnership with Novo Nordisk ...

Mallya is compatible with all Novo Nordisk FlexTouch ® insulin pens. Based on the agreement, Novo Nordisk will be commercializing Mallya in Japan from the first half of 2023.